Fresh From the Bench: Latest Federal Circuit Court Cases
Contributed by Schwabe Williamson & Wyatt. Originally published on Patexia; republished here as part of the LexDana archive.
CASE OF THE WEEK
Enplas Display Device Corp. v. Seoul Semiconductor Co., Ltd., Appeal No. 2106-2599 (Fed. Cir. Nov. 19, 2018)
In an appeal from a jury verdict and JMOLs in a patent infringement case, the Federal Circuit set new precedent concerning lump sum royalties and induced infringement.
The patents in the case concern “light bars” used to backlight flat-screen televisions. Enplas and SSC worked collaboratively to manufacture light bars that were covered by SSC’s patents. In 2012, SSC suspected that Enplas was selling the light bars to SSC’s competitors. SSC sent Enplas a letter asserting infringement, and Enplas filed a declaratory judgment action.
One of the key issues was whether Enplas had induced infringement of SSC’s patents. The jury found Enplas liable for induced infringement—selling the infringing light displays to companies that would then sell them into the United States. Enplas, a Japanese company that sold the light bars to companies like Samsung, argued that it could not be held liable for induced infringement because SSC could not prove that Enplas both knew of the existence of the patents and also knew that Enplas’s customers would sell the products in the United States. It was not disputed that Enplas knew of the patents. But with respect to knowledge of the infringement, Enplas argued that it did not know that any infringing acts would take place in the United States.
Written by: Scott D. Eads and Nika Aldrich, Schwabe Williamson & Wyatt
More insights
Federal Circuit Affirms Invalidation of Patent for Lack of Enablement of Claims Directed to a Method of Treating a Patient with a Unit Dosage in Wyeth Llc v Astrazeneca Pharmaceuticals Lp
Written by : Eric Furman, Ph.D. and Ashley C. Morales Key Takeaway: Federal Circuit invalidates patent claims directed to a method for treating non-small cell lung cancer through administration of “a unit dosage” of an irreversible epidermal…
When About Becomes Indefinite Federal Circuit Provides Guidance for Life Science Patent Applications Regarding Limits of Approximation in Enviro Tech v Safe Foods
Written by : Jason J. Jardine and Kenneth O. Aruda, Ph.D. Key Takeaway: The term “about” remains useful in biotech and pharmaceutical claims, but only if the patent provides objective guidance about what the term means. Absent that guidance,…
When Any Patent Means No Patent Federal Circuit Reverses Non Specific Verdict
Written by : Brian C. Barnes and Sophia F. Zahn OLLNOVA TECHNOLOGIES LTD. v. ECOBEE TECHNOLOGIES ULC [OPINION] Before Chen , Cunningham, and Stark. Appeal from the United States District Court for the Eastern District of Texas. Summary : A verdict form…